Logo

Banc of America Downgrades Sigma-Aldrich in Wake of Advanced Separations Buy

Oct 11, 2006
NEW YORK (GenomeWeb News) – Banc of America Securities has downgraded Sigma-Aldrich from “buy” to “neutral.”
 
On Monday, Sigma said that it had acquired Advanced Separations, a developer of products used in chiral chromatography, for an undisclosed amount.
 
Advanced Separations, based in Whippany, NJ, has annual revenue of $2 million. Sigma said the acquisition will not have a material impact on sales this year, but will be neutral to earnings in 2006 and should help it meet its growth goals over the next several years.
 
As of mid-day Wednesday, Sigma’s shares were down 2.9 percent at $74.94.

Breaking News
The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.